CryoLife looks to higher-growth haemodialysis products with Hemosphere acquisition
This article was originally published in Clinica
Executive Summary
In a continuing effort to focus on higher-growth and higher-margin devices, cardiology specialist CryoLife has agreed to acquire Hemosphere, the developer of a vascular access device for use during haemodialysis.